Introduction We present international consensus recommendations for improving diagnosis,
management and treatment access in multiple sclerosis (MS). Our vision is that these will be …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Objective: To provide new insights into the role of markers of response to interferon-β
therapy in multiple sclerosis (MS) in a multicenter setting, focusing on the relevance of MRI …

The increased value of MRI and neurophysiological tools in predicting disease evolution
and treatment response will impact the therapeutic management of multiple sclerosis, from …

Objective: To investigate the association between activity during interferon-beta (IFNβ)
therapy and disability outcomes in patients with relapsing–remitting multiple sclerosis …

Background: Disease progression and treatment efficacy vary among individuals with
multiple sclerosis. Reliable predictors of individual disease outcomes are lacking. Objective …

Background and objectives Different treatment response scoring systems in treated MS
patients exist. The objective was to assess the long-term predictive value of these systems in …

Background One of the main challenges in multiple sclerosis (MS) is to predict disease
progression based on patient characteristics and therapeutic strategies. We therefore …

Objective: To predict long-term disability outcomes in TEMSO core (NCT00134563) and
extension (NCT00803049) studies in patients with relapsing forms of MS treated with …

Background: Limited data exist regarding treatment response prediction to oral disease-
modifying therapies (DMTs) in multiple sclerosis (MS). Objectives: We assessed the capacity …